Article info
PDFClinical ethics
Informed consent and compulsory medical device registries: ethics and opportunities
- Correspondence to Dr Daniel B. Kramer, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; dkramer{at}bidmc.harvard.edu
Citation
Informed consent and compulsory medical device registries: ethics and opportunities
Publication history
- Received October 28, 2020
- Revised January 20, 2021
- Accepted January 22, 2021
- First published February 19, 2021.
Online issue publication
January 21, 2022
Article Versions
- Previous version (21 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
- Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure
- Comparison of novel oncology drugs that received dual approval from the US accelerated approval and EU conditional marketing authorisation pathways, 2006–2021: a cross-sectional study
- Implantable cardioverter defibrillators: risks accompany the life-saving benefits
- The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
- Familial risk of atrioventricular block in first-degree relatives
- Quality of evidence behind FDA approvals varies widely
- Cardiac implant registries 2006–2016: a systematic review and summary of global experiences
- Safety of serial MRI in patients with implantable cardioverter defibrillators
- Identifying optimal postmarket surveillance strategies for medical and surgical devices: implications for policy, practice and research